Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sage Tablets for Menopausal Hot Flushes
NCT02032862Phase 4Terminated
- Sponsor
- A.Vogel
- Start
- Dec 2013
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of sage extract in hot flash and hyperhidrosis (2 arms), sponsored by A.Vogel. Primary endpoint: Hyperhidrosis Disease Severity Scale at 12 weeks. Started Dec 2013; status: terminated.
02
Drugs
sage extract
03
Conditions
hot flashhyperhidrosis
Beyond the preview
Go deeper on NCT02032862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02032862.